Melanoma
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
Merck and Moderna announced on 19 August 2026 that their personalized mRNA cancer vaccine, intismeran autogene, has succeeded in its first Phase…
Most read
-
Minnesota Makes Personal Finance Course Mandatory for High School Graduation
-
UK Households With £10,000 Risk Losing £300 To Low Interest Rates
-
Selangor International Care Expo in Kuala Lumpur 2026
-
Asian & Oceanian Epilepsy Congress 2026 in Kuala Lumpur
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
Sugar‑sweetened beverages raise teen anxiety and depression risk, Australian study finds
-
How Liquid Biopsy Is Transforming Cancer Monitoring and Early Detection Strategies
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
MD Anderson Breakthroughs Advance Immunotherapy for Lung Cancer
-
How Modern Immunotherapy Is Redefining Cancer Treatment Beyond Chemotherapy
-
26% of Americans Spend More Than They Earn as Credit Card Debt Rises and Budgets Tighten
-
How Medicaid Estate Recovery Claims Decedents’ Homes Through Premiums
-
How Insurance Agent Commissions Drive Medicare Advantage Enrollments
-
How Mortgage Rates Could Shift Over the Next Five Years
-
Raising UK personal tax allowance to £18,000 would save basic-rate taxpayers £686 annually
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Dennis Lo Pioneers Liquid Biopsy for Cancer and Prenatal Testing
-
Theo Burrell’s death sparks renewed calls for brain cancer research funding
-
Thousands embrace mud and purpose at Heaton Park Pretty Muddy run.
-
Study Links Lung Tumor Mutation, High-Fat Diet, and Nerve Pathway to Wasting Syndrome
-
New Research Highlights Rising Internet Addiction Debate
-
Study Suggests Drinking Water With Meals May Lead To Overeating
-
Real-World Oncotype DX Adoption: Rates and Key Challenges
-
Energy Drinks: Youth Marketing, Caffeine Risks Under Scrutiny
-
ADHD Dopamine Dysfunction Disrupts Sleep-Wake Cycles, Study Finds